Estimating Premorbid Intellectual Functioning in Children and Measuring Change in Cognitive Functioning as Children Develop
Launched by UNIVERSITY OF ABERDEEN · Nov 5, 2019
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how children's thinking abilities change as they grow up and how to better understand these changes, especially in children who might have experienced neurological issues. The goal is to gather new information about how typical children develop their cognitive skills over time. By doing this, researchers hope to improve how doctors can identify and monitor any unusual changes in a child's thinking abilities due to injuries or illnesses.
To participate in this study, children must be between 6 and just under 17 years old, attend a local mainstream school, and speak English as their first language. It's important that they have not had any previous brain injuries or neurological conditions. Participants will be asked to take part in tests at two different times to help researchers collect the information they need. This study is not currently recruiting participants, but it aims to make significant advancements in understanding children's cognitive development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants must be aged between 6 years 0 months and 16 years 11 months 364 days
- • Participants must be enrolled into a local mainstream school and have English as their first language
- • Participants must not have sustained a previous brain-injury and not suffer from any other neurological illness (please see exclusion criteria below)
- Exclusion Criteria:
- • Individuals born significantly premature, that have a diagnosis of learning disability, a known neurological illness, or who have had a previous head-injury that required hospitalisation will be excluded from taking part in the study
- • Individuals with a current mental health problem for which they are receiving treatment or those with substance misuse problems will also be excluded
- • Participants unable to give informed consent will likewise be excluded
About University Of Aberdeen
The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, , United Kingdom
Aberdeen, Uk, United Kingdom
Patients applied
Trial Officials
Bruce Downey
Principal Investigator
NHS Grampian
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials